nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00907	0.00907	CcSEcCtD
Travoprost—Musculoskeletal pain—Vincristine—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Travoprost—Urinary incontinence—Carmustine—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Travoprost—Angina pectoris—Fludarabine—lymphatic system cancer	0.00767	0.00767	CcSEcCtD
Travoprost—Vertigo—Mechlorethamine—lymphatic system cancer	0.00761	0.00761	CcSEcCtD
Travoprost—Bronchitis—Fludarabine—lymphatic system cancer	0.00757	0.00757	CcSEcCtD
Travoprost—Dysuria—Fludarabine—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Travoprost—Injury—Bleomycin—lymphatic system cancer	0.00727	0.00727	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00716	0.00716	CcSEcCtD
Travoprost—Abnormal vision—Carmustine—lymphatic system cancer	0.00701	0.00701	CcSEcCtD
Travoprost—Arthritis—Bleomycin—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Travoprost—Infection—Mechlorethamine—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Travoprost—Urinary tract infection—Fludarabine—lymphatic system cancer	0.00683	0.00683	CcSEcCtD
Travoprost—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Travoprost—Sinusitis—Fludarabine—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Travoprost—Eye pain—Carmustine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Travoprost—Injury—Carmustine—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Travoprost—Pharyngitis—Fludarabine—lymphatic system cancer	0.00626	0.00626	CcSEcCtD
Travoprost—Skin hyperpigmentation—Methotrexate—lymphatic system cancer	0.00626	0.00626	CcSEcCtD
Travoprost—Visual impairment—Fludarabine—lymphatic system cancer	0.00607	0.00607	CcSEcCtD
Travoprost—Hypertension—Teniposide—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Travoprost—Chest pain—Teniposide—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Travoprost—Oedema—Teniposide—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Travoprost—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Travoprost—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Travoprost—Infection—Teniposide—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Travoprost—Tachycardia—Teniposide—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Travoprost—Malaise—Fludarabine—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Travoprost—Pruritus—Mechlorethamine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Travoprost—Cough—Fludarabine—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Travoprost—Hypotension—Teniposide—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Travoprost—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Travoprost—Arthralgia—Fludarabine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Travoprost—Myalgia—Fludarabine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Travoprost—Discomfort—Fludarabine—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Travoprost—Dyspnoea—Teniposide—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Travoprost—Dysuria—Vincristine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Travoprost—Depression—Carmustine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Travoprost—Oedema—Fludarabine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Travoprost—Infection—Fludarabine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Travoprost—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Travoprost—Urinary tract infection—Carmustine—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Travoprost—Rash—Mechlorethamine—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Travoprost—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Travoprost—Depression—Vincristine—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Travoprost—Feeling abnormal—Teniposide—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Travoprost—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Travoprost—Skin discolouration—Methotrexate—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Travoprost—Bone disorder—Methotrexate—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Travoprost—Nausea—Mechlorethamine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Travoprost—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Travoprost—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Travoprost—Herpes simplex—Methotrexate—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Travoprost—Abdominal pain—Teniposide—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Travoprost—Erythema—Bleomycin—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Travoprost—Dyspnoea—Fludarabine—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Travoprost—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Travoprost—Dyspepsia—Fludarabine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Travoprost—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Travoprost—Visual impairment—Carmustine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Travoprost—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Travoprost—Fatigue—Fludarabine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Travoprost—Inflammation—Methotrexate—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Travoprost—Pain—Fludarabine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Travoprost—Constipation—Fludarabine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Travoprost—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Travoprost—Urinary tract disorder—Vincristine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Travoprost—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Travoprost—Urethral disorder—Vincristine—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Travoprost—Eye disorder—Carmustine—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Travoprost—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Travoprost—Hypersensitivity—Teniposide—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Travoprost—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Travoprost—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Travoprost—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Travoprost—Asthenia—Teniposide—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Travoprost—Malaise—Bleomycin—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Travoprost—Pruritus—Teniposide—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Travoprost—Cardiac disorder—Vincristine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Travoprost—Mental disorder—Carmustine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Travoprost—Erythema—Carmustine—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Travoprost—Cough—Bleomycin—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Travoprost—Angiopathy—Vincristine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Travoprost—Diarrhoea—Teniposide—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Travoprost—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Travoprost—Chest pain—Bleomycin—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Travoprost—Myalgia—Bleomycin—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Travoprost—Back pain—Carmustine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Travoprost—Discomfort—Bleomycin—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Travoprost—Mental disorder—Vincristine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Travoprost—Vision blurred—Carmustine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Travoprost—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Travoprost—Oedema—Bleomycin—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Travoprost—Erythema—Mitoxantrone—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Travoprost—Infection—Bleomycin—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Travoprost—Back pain—Vincristine—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Travoprost—Asthenia—Fludarabine—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Travoprost—Rash—Teniposide—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Travoprost—Dermatitis—Teniposide—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Travoprost—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Travoprost—Headache—Teniposide—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Travoprost—Pruritus—Fludarabine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Travoprost—Back pain—Mitoxantrone—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Travoprost—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Travoprost—Hypotension—Bleomycin—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Travoprost—Diarrhoea—Fludarabine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Travoprost—Hypertension—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Travoprost—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Travoprost—Nausea—Teniposide—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Travoprost—Vertigo—Vincristine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Travoprost—Chest pain—Carmustine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Travoprost—Myalgia—Carmustine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Travoprost—Anxiety—Carmustine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Travoprost—Malaise—Mitoxantrone—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Travoprost—Dyspnoea—Bleomycin—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Travoprost—Hypertension—Vincristine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Travoprost—Oedema—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Travoprost—Myalgia—Vincristine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Travoprost—Cough—Mitoxantrone—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Travoprost—Infection—Carmustine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Travoprost—Rash—Fludarabine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Travoprost—Dermatitis—Fludarabine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Travoprost—Hypertension—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Travoprost—Pain—Bleomycin—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Travoprost—Headache—Fludarabine—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Travoprost—Tachycardia—Carmustine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Travoprost—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Travoprost—Chest pain—Mitoxantrone—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Travoprost—Myalgia—Mitoxantrone—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Travoprost—Anxiety—Mitoxantrone—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Travoprost—Discomfort—Mitoxantrone—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Travoprost—Oedema—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Travoprost—Infection—Vincristine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Travoprost—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Travoprost—Nervous system disorder—Vincristine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Travoprost—Hypotension—Carmustine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Travoprost—Oedema—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Travoprost—Nausea—Fludarabine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Travoprost—Infection—Mitoxantrone—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Travoprost—Tachycardia—Mitoxantrone—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Travoprost—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Travoprost—Hypotension—Vincristine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Travoprost—Dyspnoea—Carmustine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Travoprost—Hypotension—Mitoxantrone—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Travoprost—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Travoprost—Pain—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Travoprost—Constipation—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Travoprost—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Travoprost—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Travoprost—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Travoprost—Feeling abnormal—Carmustine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Travoprost—Fatigue—Vincristine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Travoprost—Asthenia—Bleomycin—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Travoprost—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Travoprost—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Travoprost—Pain—Vincristine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Travoprost—Constipation—Vincristine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Travoprost—Asthma—Methotrexate—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Travoprost—Pruritus—Bleomycin—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Travoprost—Fatigue—Mitoxantrone—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Travoprost—Pain—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Travoprost—Constipation—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Travoprost—Abdominal pain—Carmustine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Travoprost—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Travoprost—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Travoprost—Dysuria—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Travoprost—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Travoprost—Abdominal pain—Vincristine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Travoprost—Hypersensitivity—Carmustine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Travoprost—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Travoprost—Infestation—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Travoprost—Infestation NOS—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Travoprost—Depression—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Travoprost—Rash—Bleomycin—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Travoprost—Dermatitis—Bleomycin—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Travoprost—Asthenia—Carmustine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Travoprost—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Travoprost—Hypersensitivity—Vincristine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Travoprost—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Travoprost—Asthenia—Vincristine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Travoprost—Diarrhoea—Carmustine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Travoprost—Nausea—Bleomycin—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Travoprost—Asthenia—Mitoxantrone—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Travoprost—Dizziness—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Travoprost—Diarrhoea—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Travoprost—Pharyngitis—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Travoprost—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Travoprost—Urethral disorder—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Travoprost—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Travoprost—Dizziness—Vincristine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Travoprost—Rash—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Travoprost—Dermatitis—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Travoprost—Visual impairment—Methotrexate—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Travoprost—Headache—Carmustine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Travoprost—Eye disorder—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Travoprost—Tinnitus—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Travoprost—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Travoprost—Rash—Vincristine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Travoprost—Dermatitis—Vincristine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Travoprost—Headache—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Travoprost—Nausea—Carmustine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Travoprost—Angiopathy—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Travoprost—Immune system disorder—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Travoprost—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Travoprost—Rash—Mitoxantrone—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Travoprost—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Travoprost—Headache—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Travoprost—Mental disorder—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Travoprost—Erythema—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Travoprost—Nausea—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Travoprost—Dysgeusia—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Travoprost—Nausea—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Travoprost—Back pain—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Travoprost—Vision blurred—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Travoprost—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Travoprost—Malaise—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Travoprost—Vertigo—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Travoprost—Cough—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Travoprost—Arthralgia—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Travoprost—Chest pain—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Travoprost—Myalgia—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Travoprost—Discomfort—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Travoprost—Infection—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Travoprost—Nervous system disorder—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Travoprost—Skin disorder—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Travoprost—Hypotension—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Travoprost—Dyspnoea—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Travoprost—Dyspepsia—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Travoprost—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Travoprost—Fatigue—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Travoprost—Pain—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Travoprost—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Travoprost—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Travoprost—Abdominal pain—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Travoprost—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Travoprost—Asthenia—Methotrexate—lymphatic system cancer	0.000953	0.000953	CcSEcCtD
Travoprost—Pruritus—Methotrexate—lymphatic system cancer	0.000939	0.000939	CcSEcCtD
Travoprost—Diarrhoea—Methotrexate—lymphatic system cancer	0.000908	0.000908	CcSEcCtD
Travoprost—Dizziness—Methotrexate—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Travoprost—Rash—Methotrexate—lymphatic system cancer	0.000837	0.000837	CcSEcCtD
Travoprost—Dermatitis—Methotrexate—lymphatic system cancer	0.000836	0.000836	CcSEcCtD
Travoprost—Headache—Methotrexate—lymphatic system cancer	0.000832	0.000832	CcSEcCtD
Travoprost—Nausea—Methotrexate—lymphatic system cancer	0.000789	0.000789	CcSEcCtD
